ALFA Finder| Management target | Revenue 12.5% FY27 |
|---|
| Revenue growth | 9% YoY growth in Q1 FY27. |
|---|---|
| Margins | Gross margins improved to 36.7%; targeting 18-20% EBITDA. |
| Demand visibility | Restocking in Europe reaching normal levels. |
| Management confidence | High for volume recovery in Europe. |
Growth
Revenue up 9%; Agrochemicals grew 8%, non-Agro 15%. EBITDA rose 25% due to better product mix and geographic performance.
Outlook
FY27 guidance maintained at 10%-15% revenue growth; EBITDA margins 18%-20%; registrations capex Rs 500-550Cr.
Risks
Unfavorable weather in Europe (heatwaves) impacted volumes; FX volatility and high amortization costs (Rs 370-375Cr expected).
Last quarter's promises, checked
Delivered
- Guided FY26 Gross Margins ~35% → delivered 35.9% (= BEAT)
- Guided FY26 CAPEX ~Rs 500Cr → delivered Rs 505Cr (= BEAT)
- Guided FY26 status as debt-free → delivered zero-debt (= BEAT)
Partly delivered
- Guided Q4 FY26 EBITDA margins 18%-20% → delivered 24.8% (Quarterly beat, but FY26 19.7% = PARTIAL)
Missed
- Guided Q4 FY26 Revenue growth 15%-20% → delivered 13% (= MISS)
Investor Presentation filed with BSE, NSE: SHARDACROP. Summary written with AI assistance from the document.
Sharda Cropchem Ltd: key numbers
- Share price
- ₹710.95
- Market cap
- ₹6,414 Cr
- Revenue (annual)
- ₹5,268 Cr
- Net profit (annual)
- ₹680.9 Cr
- P/E (TTM)
- 10.0×Sector 35.5×
- Promoter holding
- 74.82%+0.00% QoQ
- FII holding
- 3.27%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Sharda Cropchem Ltd
All →Sharda Cropchem Earnings Call Transcript: Key Takeaways
Sharda Cropchem delivered double-digit revenue growth and margin expansion, led by strong performance in NAFTA and LATAM, despite European weather headwinds and volume de-growth.
- Call
- Guides 15% growth
Sharda Cropchem Results Update
Sharda Cropchem's Q2 FY27 revenue rose 13% to ₹1,052 crore; EBITDA grew 18% to ₹164 crore. H1 PAT declined 17% to ₹180 crore on lower forex gains.
Sharda Cropchem Investor Presentation: Key Takeaways
Q2 FY27 consolidated revenue Rs 1,052 Cr (+13%), EBITDA Rs 164 Cr (+18%), margin 15.6%, PAT Rs 92 Cr (+23%). H1 PAT down 17%.
Sharda Cropchem Q2 FY27 Results: Net Profit ₹91.7 Cr, Up 23.3% YoY
Sharda Cropchem Ltd reported revenue from operations of ₹1,052 Cr (+13.2% YoY) and net profit of ₹91.7 Cr (+23.3% YoY) for Q2 FY27.
- Key figure
- Net profit ₹91.7 Cr · +23.3% YoY
Sharda Cropchem Board Meeting Date
Sharada Cropchem scheduled a board meeting for 30 Oct 2026 to consider its H1 FY27 unaudited financial results. No financial figures or decisions are reported in this advance intimation.
Sharda Cropchem Other Announcement
Sharda Cropchem Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026, as required by SEBI regulations.